IP Library › Granted Patent US 10,859,585
Granted Patent B2
US 10,859,585 · App. 16/235,096 · Granted Dec 8, 2020

Lipid probes and uses thereof

Inventors: Benjamin F. Cravatt (La Jolla, CA); Micah J. Niphakis (San Diego, CA); Kenneth Lum (San Diego, CA); Bruno Correia (Blemblens, CH); Armand Cognetta (San Diego, CA); Jonathan Hulce (Libertyville, IL)
Assignee: The Scripps Research Institute
G01N33/92G01N33/6842G01N2500/04G01N2570/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,859,585
App. No.
16/235,096
Granted
Dec 8, 2020
Kind
B2
Abstract

Disclosed herein are methods, compositions, probes, assays and kits for identifying a lipid binding protein as a drug binding target. Also disclosed herein are methods, compositions, and probes for mapping a ligand binding site on a lipid binding protein, identification of lipid binding proteins, generating drug-lipid binding protein profiles, high throughput drug screening, and identification of drugs as potential lipid binding protein ligands.

Claims (35)

1. A process of generating a lipid probe-protein composition, comprising:

contacting a sample comprising a protein with a lipid probe; and

treating the sample and the lipid probe by a photoreactive means to generate the lipid probe-protein composition, wherein the treating time is from about 5 minutes to about 1 hour; and

wherein the lipid probe is a lipid probe of Formula (I):

wherein:

A is C 16 -C 20 alkyl or C 16 -C 20 alkenyl;

D is —NH 2 , —NHR 7 , or —OR 8 ;

R 7 is C 1 -C 4 alkyl, (C 1 -C 5 alkyl)OH, or (C 1 -C 5 )SO 3 M;

R 8 is (CH 2 OH)n;

M is monovalent or divalent cation;

n is 1, 2, or 3;

PG is a photoreactive group; and

AH is an affinity handle; and

wherein PG is attached to A or D and AH is attached to A or D.

2. The process of claim 1 , wherein the treating time is about 10 minutes.

3. The process of claim 1 , wherein the photoreactive group comprises azides, benzophenone, diazo compounds, diazirines, diazonium salts, or diaryl ketones.

4. The process of claim 1 , wherein the affinity handle comprises a carbodiimide, N-hydroxysuccinimide (NHS) ester, imidoester, pentafluorophenyl ester, hydroxymethyl phosphine, maleimide, haloacetyl, pyridyl disulfide, thiosulfonate, vinylsulfone, hydrazide, alkoxyamine, alkyne, azide, or isocyanate group.

5. The process of claim 1 , wherein the protein is an enzyme, a transporter, a receptor, an adaptor, a channel protein, or a chaperone.

6. The process of claim 1 , wherein the protein is encoded by a gene of Table 3, a protein encoded by a gene of Table 4, or a protein encoded by a gene of Table 5.

7. The process of claim 1 , wherein the photoreactive means comprises ultraviolet light.

8. The process of claim 1 , wherein the treating occurs at a temperature of from about 0° C. to about 40° C.

9. The process of claim 1 , wherein the treating occurs at a temperature of about 4° C.

10. A lipid probe-protein composition generated by the process of claim 2 .

11. A process of generating a lipid probe-protein composition, comprising:

contacting a sample comprising a protein with a lipid probe, wherein the lipid probe is selected from lipid probes 1, 3-10, 12-15, 17-21 and 23 of Table 1; and

treating the sample and the lipid probe by a photoreactive means to generate the lipid probe-protein composition, wherein the treating time is from about 5 minutes to about 1 hour.

12. The process of claim 11 , wherein the treating time is about 10 minutes.

13. The process of claim 11 , wherein the photoreactive group comprises azides, benzophenone, diazo compounds, diazirines, diazonium salts, or diaryl ketones.

14. The process of claim 11 , wherein the affinity handle comprises a carbodiimide, N-hydroxysuccinimide (NHS) ester, imidoester, pentafluorophenyl ester, hydroxymethyl phosphine, maleimide, haloacetyl, pyridyl disulfide, thiosulfonate, vinylsulfone, hydrazide, alkoxyamine, alkyne, azide, or isocyanate group.

15. The process of claim 11 , wherein the protein is an enzyme, a transporter, a receptor, an adaptor, a channel protein, or a chaperone.

16. The process of claim 11 , wherein the protein is encoded by a gene of Table 3, a protein encoded by a gene of Table 4, or a protein encoded by a gene of Table 5.

17. The process of claim 11 , wherein the photoreactive means comprises ultraviolet light.

18. The process of claim 11 , wherein the treating occurs at a temperature of from about 0° C. to about 40° C.

19. The process of claim 11 , wherein the treating occurs at a temperature of about 4° C.

20. A lipid probe-protein composition generated by the process of claim 11 .

Continuity (3)
Division 15080767 · Mar 25, 2016
Provisional Application 62139576 · Mar 27, 2015
Related Publication 20190293666A1 · Sep 26, 2019
Cited By (1)
US 12,650,436